Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Johnson & Johnson has had a great year largely because of its hepatitis C drug Olysio. This top dividend stock, though, might reverse course in 2015. Here's why.
3 Stocks the Smartest Investors Are Buying Right Now
Just because stocks have rallied over the last few years to record heights doesn't mean that smart investors aren't buying stocks.